Cogstate’s digital cognitive testing system Cognigram is now available in the U.S. after Cogstate was notified by the U.S.
Alice Melão
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melão
The advances scientists have made in identifying dementia symptoms include the hallmarks of Lewy body dementia, the third most prevalent…
Epileptic-seizure-like activity in a brain region called the hippocampus may contribute to the development of Alzheimer’s, according to a case study…
A once-weekly transdermal patch delivers the most commonly prescribed treatment for Alzheimer’s disease in a way that is biologically equivalent to…
Aquinnah Pharmaceuticals has received $10 million from two pharmaceutical companies, Pfizer and AbbVie, to advance its treatments…
Results from four recent studies confirmed the beneficial clinical effects of Namenda (memantine), an FDA-approved Alzheimer’s therapy, to treat the disease’s behavioral…
Two therapies — one approved and the other already in clinical testing — were seen in a study in mice…
A nationwide case-control study conducted by researchers from the University of Eastern Finland found an association between mental and behavioral…
Concussions can accelerate brain deterioration and cognitive decline in people genetically predisposed to Alzheimer’s, leading to earlier onset of the…